Asymptomatic liver injury due to erythromycin stearate.
A 73-year-old woman with rosacea, who had started treatment with erythromycin stearate 2 g/d, developed asymptomatic liver injury. The drug was discontinued and the laboratory findings of liver damage disappeared within 11 days. This is the first report of erythromycin stearate-induced asymptomatic hepatotoxicity.
D000368:Aged; D004917:Erythromycin / Q000009:adverse effects / Q000031:analogs & derivatives*; D005260:Female; D006801:Humans; D008099:Liver / Q000187:drug effects* / Q000201:enzymology
D004917:Erythromycin; C011462:erythromycin stearate